Literature DB >> 30018083

Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.

Elke Miess1, Arisbel B Gondin2, Arsalan Yousuf3, Ralph Steinborn1, Nadja Mösslein4, Yunshi Yang4, Martin Göldner4, Julia G Ruland4, Moritz Bünemann4, Cornelius Krasel4, MacDonald J Christie3, Michelle L Halls2, Stefan Schulz5, Meritxell Canals6.   

Abstract

G protein receptor kinases (GRKs) and β-arrestins are key regulators of μ-opioid receptor (MOR) signaling and trafficking. We have previously shown that high-efficacy opioids such as DAMGO stimulate a GRK2/3-mediated multisite phosphorylation of conserved C-terminal tail serine and threonine residues, which facilitates internalization of the receptor. In contrast, morphine-induced phosphorylation of MOR is limited to Ser375 and is not sufficient to drive substantial receptor internalization. We report how specific multisite phosphorylation controlled the dynamics of GRK and β-arrestin interactions with MOR and show how such phosphorylation mediated receptor desensitization. We showed that GRK2/3 was recruited more quickly than was β-arrestin to a DAMGO-activated MOR. β-Arrestin recruitment required GRK2 activity and MOR phosphorylation, but GRK recruitment also depended on the phosphorylation sites in the C-terminal tail, specifically four serine and threonine residues within the 370TREHPSTANT379 motif. Our results also suggested that other residues outside this motif participated in the initial and transient recruitment of GRK and β-arrestins. We identified two components of high-efficacy agonist desensitization of MOR: a sustained component, which required GRK2-mediated phosphorylation and a potential soluble factor, and a rapid component, which was likely mediated by GRK2 but independent of receptor phosphorylation. Elucidating these complex receptor-effector interactions represents an important step toward a mechanistic understanding of MOR desensitization that leads to the development of tolerance and dependence.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30018083     DOI: 10.1126/scisignal.aas9609

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  40 in total

1.  Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs.

Authors:  Emily R Leff; Seksiri Arttamangkul; John T Williams
Journal:  Mol Pharmacol       Date:  2020-05-03       Impact factor: 4.436

2.  Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neurochem       Date:  2019-10-20       Impact factor: 5.372

3.  Homologous Regulation of Mu Opioid Receptor Recycling by G βγ , Protein Kinase C, and Receptor Phosphorylation.

Authors:  Jennifer M Kunselman; Amanda S Zajac; Zara Y Weinberg; Manojkumar A Puthenveedu
Journal:  Mol Pharmacol       Date:  2019-10-01       Impact factor: 4.436

Review 4.  A cellular perspective of bias at G protein-coupled receptors.

Authors:  Thomas J Fernandez; Monica De Maria; Braden T Lobingier
Journal:  Protein Sci       Date:  2020-04-27       Impact factor: 6.725

Review 5.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

6.  Separation of Acute Desensitization and Long-Term Tolerance of µ-Opioid Receptors Is Determined by the Degree of C-Terminal Phosphorylation.

Authors:  Seksiri Arttamangkul; Emily R Leff; Omar Koita; William T Birdsong; John T Williams
Journal:  Mol Pharmacol       Date:  2019-08-05       Impact factor: 4.436

7.  A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor.

Authors:  Renee A Bouley; Zara Y Weinberg; Helen V Waldschmidt; Yu-Chen Yen; Scott D Larsen; Manojkumar A Puthenveedu; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2020-03-31       Impact factor: 4.436

Review 8.  Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Cell Mol Neurobiol       Date:  2020-08-17       Impact factor: 5.046

Review 9.  Biased ligands at opioid receptors: Current status and future directions.

Authors:  Tao Che; Hemlata Dwivedi-Agnihotri; Arun K Shukla; Bryan L Roth
Journal:  Sci Signal       Date:  2021-04-06       Impact factor: 8.192

10.  Targeting G protein-coupled receptor kinases (GRKs) to G protein-coupled receptors.

Authors:  Sarah M Sulon; Jeffrey L Benovic
Journal:  Curr Opin Endocr Metab Res       Date:  2020-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.